報價延遲最少15分鐘:2025/05/31 21:16 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.41 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.49/-1.01
|
|
企業價值
80.91M
|
| 資產負債 |
|
每股賬面淨值
0.40
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/05/31 21:16 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. |